Skip to main content
logo
Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
2.650
-0.360 (-11.96%)
At close: Oct 14, 2026, 4:00 PM EDT
3.220
+0.570 (21.50%)
After-hours: Oct 14, 2026, 4:46 PM EDT

Addex Therapeutics Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.080.170.411.621.443.15
Revenue Growth
-50.34%-57.84%-74.64%11.92%-54.18%-18.71%
Gross Profit
-0.27-0.5-0.440.43-6.78-9.67
Operating Income
-2.6-2.81-2.76-2.24-10.54-15.51
Net Income
-6.87-6.737.06-10.56-20.8-15.35
Earnings Per Share
-0.06-0.060.07-0.14-0.46-0.45
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.771.643.343.876.9620.48
Total Debt
0.080.030.040.340.370.48
Net Cash (Debt)
0.691.63.33.526.5820
Net Cash Growth
-69.51%-51.39%-6.29%-46.52%-67.08%10.34%
Net Cash Per Share
0.010.010.030.050.150.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.39-2.17-5.37-7.99-16.44-14.71
Capital Expenditures
---0-0.01-0-0.03
Free Cash Flow
-2.39-2.17-5.37-8-16.44-14.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--288.55%-108.35%26.62%--
Operating Margin
-3130.67%-1628.25%-671.94%-138.70%-729.50%-491.74%
Pretax Margin
-8266.90%-3958.46%-1197.28%-154.60%-747.70%-486.85%
Profit Margin
-8271.00%-3892.31%1720.75%-652.75%-1439.78%-486.85%
FCF Margin
-2873.12%-1256.00%-1310.80%-494.64%-1137.59%-467.34%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.80---
PS Ratio
34.8337.3613.723.827.1912.50